Docetaxel

Cognitive Impairment Common With Adjuvant Therapy in Older Patients With Early Stage Breast Cancer

Cognitive Impairment Common With Adjuvant Therapy in Older Patients With Early Stage Breast Cancer

By

Cognitive decline associated with adjuvant chemotherapy was more likely to occur in older patients, particularly those whose treatment included docetaxel.

Genetic Biomarker Predictive of Peripheral Neuropathy in Patients Receiving Docetaxel for Prostate Cancer

By

Docetaxel-induced neuropathy may be predicted by single nucleotide polymorphisms in VAC14.

Can docetaxel cause intoxication in cancer patients?

Can docetaxel cause intoxication in cancer patients?

The FDA issued an alert last Friday that some patients have reported feeling intoxicated after receiving their infusions of the chemotherapeutic drug, docetaxel.

Study Results Demonstrate A New Prostate Cancer Treatment

Study Results Demonstrate A New Prostate Cancer Treatment

A new study is suggesting a different approach to treating prostate cancer. Researchers at Comprehensive Cancer Centers of Nevada conducted a study in which 790 men with advanced stages of prostate cancer received early chemotherapy.

Zytiga approved for metastatic prostate cancer

The FDA has expanded the indication for abiraterone acetate (Zytiga tablets) to combat metastatic castration-resistant prostate cancer.

Some breast cancers may respond to anti-androgen drug

By

Newly approved for prostate cancer, enzalutamide may be useful as a therapeutic agent in breast cancer that evades other treatments.

Noninvasive technique predicts patients' response to chemotherapy

By

Positron emission tomography (PET) can non-invasively predict how much of a cancer-killing drug is absorbed by a tumor. This preliminary study, conducted in lung cancer patients, found that less than 1% of docetaxel is absorbed by the tumors.

Noninvasive technique predicts patients' response to chemotherapy

By

Positron emission tomography (PET) can non-invasively predict how much of a cancer-killing drug is absorbed by a tumor. This preliminary study, conducted in lung cancer patients, found that less than 1% of docetaxel is absorbed by the tumors.

Taxanes do more than stop prostate tumor cell division

New insights into the action of taxanes on androgen receptors in prostate cancer shed light on why a patient may not respond to these drugs.

Abiraterone proves worthy against prostate cancer

Abiraterone markedly prolongs survival in men with metastatic castration-resistant prostate cancer that has progressed after docetaxel therapy.

Survival in patients with advanced lung cancer improved with new drug

By

Overall survival was twice as long in patients with advanced lung cancer who received bavituximab compared with patients who did not receive the drug, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

FDA Update - July/August 2012

News about pertuzumab injection (Perjeta); ondansetron (Zofran); carfilzomib (Kyprolis); Therascreen KRAS RGQ PCR Kit; Prostate Health Index (phi); and Prepopik

VEGF blockade: Optimizing chemotherapy drug uptake

VEGF blockade: Optimizing chemotherapy drug uptake

By

New research is showing that sequence and timing have significant impact on the efficacy of therapeutic regimens that include bevacizumab.

New drugs change treatment landscape for advanced prostate cancer

Several newly approved drugs plus more in the pipeline present the real possibility of prolonging survival in men with advanced prostate cancer.

Pertuzumab enhances outcomes in HER2-positive breast cancer

Women with HER2-positive breast cancer had an improved rate of complete tumor disappearance in just 12 weeks when the monoclonal antibody pertuzumab was added to standard therapy.

Adjuvant therapy in breast cancer

Weekly paclitaxel adjuvant therapy for breast cancer may result in better overall survival than other regimens, the results of a US study suggest.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs